| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |